• HealthHack
  • Posts
  • šŸ’¤ Sleep Tech, Brain Chips, and Sex Ed Meets Rx – This Week in Health

šŸ’¤ Sleep Tech, Brain Chips, and Sex Ed Meets Rx – This Week in Health

Some Fresh HealthTech Updates for you

Hi there šŸ‘‹ 

Welcome to the first official issue of HealthHack under the EU-Startups banner—along with a newly newsletter template highlighting the innovations reshaping how we care for our bodies and our future.

Each edition brings you HealthTech that’s smart, human-centered, and built to solve real problems—tools that don’t just treat, but transform.

This week’s lineup shows HealthTech going straight for your everyday reality. Whether it's dodging 10-week hospital queues, dialing into your brain's electrical grid, or tackling the silent epidemic of sleep apnea (and its not-so-silent symptoms), we’re seeing real solutions for real problems.

Consider this your curated pass to smarter sleep, smarter sex, and smarter care.

At HealthHack, we spotlight companies making recent meaningful progress —whether through scientific breakthroughs, new applications, or expanding access to life-changing treatments.

Stick around for the Quote of the Week and a Poll!

EDITOR’S CHOICE ✨ 

Silent Nights Are Coming

šŸ’¤ Say goodbye to earplugs and hello to actual sleep.

Zeus Sleep is tackling the under-treated world of sleep apnea with a consumer-first device that’s equal parts brainy and bedside-ready.

Designed to detect breathing irregularities in real time, their tech not only intervenes mid-snore but also supports diagnosis and continuous care—making it easier than ever to spot (and stop) the kind of sleep disturbances that can quietly wreck your long-term health.

For the millions struggling through fatigue, fog, and frustrated partners, this is your peace-and-quiet moonshot.

Mental Health & Behavior

The brain is getting a hardware upgrade. From Parkinson’s to precision implants, new NeuroTech is reshaping how we understand and intervene in mental and neurological health.

šŸ•¶ļø Your Brain, But Upgraded

INBRAIN Neuroelectronics is pushing the envelope with graphene-powered brain-computer interfaces. This new tech promises to monitor and modulate brain activity with jaw-dropping precision, potentially offering relief for conditions like epilepsy and Parkinson’s—not to mention new possibilities in cognitive enhancement. šŸ”— Read more

🧠 Parkinson’s Drug in the Pipeline

Umecrine Cognition is bringing a new candidate to the table for Parkinson’s patients. Golexanolone works by targeting excessive neural inhibition, aiming to reduce cognitive symptoms that make daily life so tough for those with the condition. Backed by the Michael J. Fox Foundation, this could mark a major step forward. šŸ”— Read more

VISIONARY VOICES šŸ’¬

Fueling the Fight Against PMD

For the 250,000+ people living with primary mitochondrial disease (PMD), there are still zero approved treatments. Khondrion is aiming to change that.

Backed by new government support, the company is gearing up for Phase 3 trials of sonlicromanol—a first-in-class drug designed to modify the disease at its root, not just manage symptoms. With years of safety data, promising Phase 2 results, and orphan drug designations across the EU and US, this could be the first real breakthrough for patients whose cells can’t generate energy properly.

The result? A shot at stability, strength, and a better quality of life.

Chronic Care, Reimagined

Chronic doesn’t mean unchangeable. These new therapies are targeting the root causes of long-term conditions—with molecular precision and bold biotech bets.

ā™„ļø RNA, Rewritten for You

Haya Therapeutics is engineering RNA-guided therapies for chronic and age-related illnesses, including heart failure and fibrosis. It’s an ambitious move toward medications that act with scalpel-like precision at the molecular level. šŸ”— Read more

šŸ”¬ Oncology, Refocused

Oniria Therapeutics is taking a new approach to cancer treatment—targeting the cell cycle to disrupt how tumors survive and grow. With more selective action, this could mean fewer side effects and stronger outcomes. šŸ”— Read more

Prevention & Precision

Healthcare is finally meeting you where you are. From embedded prescriptions to AI-powered drug discovery, precision is going mainstream—and fast.

šŸŒ‹ Care, Embedded in Pleasure

In a move that's as innovative as it is practical, Evaro is integrating NHS prescriptions directly into the Lovehoney platform. From sexual health meds to free contraception, users can now access GP consultations and medications—without ever leaving the site. šŸ”—Read more

šŸ’Š Machine Learning That Could Save Your Life

CryoCloud, a BioTech company, is supercharging drug discovery with machine learning. By using AI to sift through massive molecular datasets, they're identifying potential new therapies faster and more affordably—bringing hope for quicker cures and fewer clinical dead ends. šŸ”— Read more

POLL: How do you like the redesign?

Login or Subscribe to participate in polls.

Digital Infrastructure

Behind the scenes, the system is getting smarter. Tech-driven platforms are fixing the admin drag and data chaos that slow down care—so the focus can shift back to patients.

🫵 Data That Works for You

ReportAId is turning messy, siloed patient data into actionable, AI-driven insights. The goal? Better diagnostics, faster interventions, and fewer errors—so your health records finally start feeling like an asset instead of a burden. šŸ”— Read more

šŸ“‹ Smarter Systems, Healthier Outcomes

Cavell is rebuilding the digital guts of healthcare systems to reduce admin drag and actually center patients in the process. Less time on forms, more time on you. šŸ”—Read More

🌐 Scaling Digital Chronic Care

Dawn Health is taking its chronic care management platform global. Designed to support patients with long-term conditions like diabetes and cardiovascular disease, the platform blends remote monitoring, personalized nudges, and behavioral support—making chronic care feel less like a chore and more like support. šŸ”— Read more

šŸ­ Industrial-Scale Innovation for Pharma

Reig Jofre is injecting digital intelligence into pharmaceutical R&D and production with its new initiative under the EU’s IPCEI Med4Cure project. The goal: smarter manufacturing processes that can accelerate innovation and make next-gen therapies more accessible, more quickly. šŸ”— Read more

Well that’s it! šŸš€ 

This week’s stories prove one thing: the future of healthcare isn’t abstract—it’s personal.

From bedside monitors to browser-based medicine, this issue proves one thing: HealthTech is showing up where you need it most. Quietly, discreetly, and sometimes even overnight.

At HealthHack, we’ll keep tracking the innovations making your life healthier—even when you're not looking.

Until next time, stay curious, stay inspired, and stay healthy.

— The HealthHack Team

P.S. See the below Quote of the Week!

ā

ā€œSexual health and wellness shouldn’t be hindered by healthcare access barriers.ā€

– Dr. Thuria Wenbar, CEO and Co-founder of Evaro